Gastrointestinal disorders and of COVID-19

To go to the COVID-19 project topics list, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]Tayyaba Ali, M.D.[3]

Overview

Transmission of COVID-19 through gastrointestinal route

SARS-CoV-2 has been detected in non-respiratory specimens, together with stool, blood, ocular secretions, and semen. However, the role of those sites in the transmission is unsure.^[1]

Gastrointestinal risk factors of COVID-19

Complications

Diarrhea

Nauesa and vomiting

Abdominal pain

Loss of appetite

References

↑ Chen, Weilie; Lan, Yun; Yuan, Xiaozhen; Deng, Xilong; Li, Yueping; Cai, Xiaoli; Li, Liya; He, Ruiying; Tan, Yizhou; Deng, Xizi; Gao, Ming; Tang, Guofang; Zhao, Lingzhai; Wang, Jinlin; Fan, Qinghong; Wen, Chunyan; Tong, Yuwei; Tang, Yangbo; Hu, Fengyu; Li, Feng; Tang, Xiaoping (2020). "Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity". Emerging Microbes & Infections. 9 (1): 469–473. doi:10.1080/22221751.2020.1732837. ISSN 2222-1751.

[ChenLan2020-1] Chen, Weilie; Lan, Yun; Yuan, Xiaozhen; Deng, Xilong; Li, Yueping; Cai, Xiaoli; Li, Liya; He, Ruiying; Tan, Yizhou; Deng, Xizi; Gao, Ming; Tang, Guofang; Zhao, Lingzhai; Wang, Jinlin; Fan, Qinghong; Wen, Chunyan; Tong, Yuwei; Tang, Yangbo; Hu, Fengyu; Li, Feng; Tang, Xiaoping (2020). "Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity". Emerging Microbes & Infections. 9 (1): 469–473. doi:10.1080/22221751.2020.1732837. ISSN 2222-1751.

[1]